Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015561 · ClinicalTrials.gov registry record
Pesticides--Health Fertility and Reproductive Risk
A clinical trial of Cancer and Birth Defects, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 1,803
- Enrollment target
- 1
- Study location
NCT00015561 is a study of Cancer and Birth Defects that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 1,803 participants, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00015561, a study of Cancer and Birth Defects, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 1,803 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is designed to establish whether pesticides or other environmental agents have a role in the excess birth defects identified in the Red River Valley of Minnesota. In this human study, laboratory based health parameters will be used to key in health survey data. In vitro data will be developed to mechanistic information. Concordant results among these study features will provide a weight of evidence approach.
Conditions Studied
Study Locations (1)
Minnesota
- University of Minnesota Medical School - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,803 participants |
| Start Date | 1996-09 |
| Est. Completion | 2001-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00015561
The ClinicalTrials.gov registry entry for NCT00015561 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,803 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (48% lower). The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00015561 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00015561 about?
NCT00015561 is a clinical study titled "Pesticides--Health Fertility and Reproductive Risk". This project is designed to establish whether pesticides or other environmental agents have a role in the excess birth defects identified in the Red River Valley of Minnesota. In this human study, laboratory based health parameters will be used to key in health survey data. In vitro data will be dev...
What is the current status of trial NCT00015561?
This trial is currently completed. The enrollment target is 1,803 participants. The study started on 1996-09. Estimated completion is 2001-08.
What conditions does trial NCT00015561 study?
This clinical trial studies the following conditions: Cancer, Birth Defects, Miscarriages.
Who is sponsoring clinical trial NCT00015561?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00015561 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.